Pittman Scott M. - 23 Jan 2026 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: AURX
Reported as of: 23 Jan 2026
Net transaction value: +$111,474
SEC form: 4
Accepted by SEC: 26 Jan 2026, 18:44:05 UTC
Prior SEC filing: 01 Aug 2025
Next SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David Jorden, attorney-in-fact

Filing notes and source

Key filing fact

Pittman Scott M. filed Form 4 for Nuo Therapeutics, Inc. (AURX) on 26 Jan 2026.

Key facts

This page summarizes Pittman Scott M.'s Form 4 filing for Nuo Therapeutics, Inc. (AURX).
6 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 26 Jan 2026, 18:44.

Change

Previous filing in this sequence was filed on 01 Aug 2025.
Current net transaction value: +$111,474.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001674752 Primary reporting owner

Pittman Scott M.

Relationship: Director, 10%+ Owner
Address: C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON
Signature: /s/ David Jorden, attorney-in-fact
Signature date: 26 Jan 2026

This filing has been restated. Open the amended filing.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURX transaction Derivative

Commitment Warrants (right to buy)

Award

Transaction value: $3,075
Shares: +2,050
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,050
Exercise price: $1.50

AURX transaction Derivative

Origination Initial Warrants (right to buy)

Award

Transaction value: $2,000
Shares: +1,333
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,333
Exercise price: $1.50

AURX transaction Derivative

Capital Initial Warrants (right to buy)

Award

Transaction value: $40,000
Shares: +26,667
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,667
Exercise price: $1.50

AURX transaction Derivative

Origination Second Warrants (right to buy)

Award

Transaction value: $2,625
Shares: +1,750
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,750
Exercise price: $1.50
Footnotes: F1

AURX transaction Derivative

Capital Second Warrants (right to buy)

Award

Transaction value: $52,500
Shares: +35,000
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $1.50
Footnotes: F1

AURX transaction Derivative

Prepayment Warrants (right to buy)

Award

Transaction value: $11,274
Shares: +7,516
Change %
Price: $1.50
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,516
Exercise price: $1.50
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the "Loan Agreement").

Footnote F2

Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement.

Footnote F3

Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement. The Board of Directors of Issuer and Non-Employee Directors approved the Loan Agreement and issuance of warrants and shares of Common Stock issuable thereunder